The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic - British Journal of Cancer
- ️Burkitt, DP
- ️Tue Dec 01 1998
Abstract
Estimated incidence rates are presented for three human immunodeficiency virus (HIV)-associated cancers [Kaposi's sarcoma (KS), Burkitt's lymphoma (BL) and other non-Hodgkin's lymphomas (NHLs)] from across the African continent, based on data collected before the HIV epidemic. Mapping of the rates and comparisons with a range of geographical variables indicate completely different distributions for KS and BL but a degree of similarity in the occurrence of Burkitt's lymphoma and other NHLs. Comparisons with rates elsewhere in the world suggest, most notably, that KS was as common in some regions of sub-Saharan Africa as was cancer of the colon in much of Western Europe. Comparison with data from the era of AIDS indicates 20-fold increases in the occurrence of Kaposi's sarcoma in Uganda and Zimbabwe. The highest rates for BL were three to four times the rates for leukaemia at young ages in Western populations, but the general incidence of other NHL was no higher than in the West and very low rates were indicated for much of southern Africa.
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
Department of Public Health, CRC Cancer Epidemiology Research Group, Radcliffe Infirmary, University of Oxford, UK
P Cook-Mozaffari
Authors
- P Cook-Mozaffari
- R Newton
- V Beral
- DP Burkitt
Rights and permissions
About this article
Cite this article
Cook-Mozaffari, P., Newton, R., Beral, V. et al. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 78, 1521–1528 (1998). https://doi.org/10.1038/bjc.1998.717
Issue Date: 01 December 1998
DOI: https://doi.org/10.1038/bjc.1998.717
This article is cited by
-
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine
- Corey Casper
- Lawrence Corey
- Charles Wood
npj Vaccines (2022)
-
SOX5 Regulates Cell Proliferation, Apoptosis, Migration and Invasion in KSHV-Infected Cells
- Wu-Mei Yuan
- Ya-Ge Fan
- Yan Zeng
Virologica Sinica (2021)
-
Kaposi sarcoma
- Ethel Cesarman
- Blossom Damania
- Denise Whitby
Nature Reviews Disease Primers (2019)
-
Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis
- Lijun Yan
- Vladimir Majerciak
- Ke Lan
Virologica Sinica (2019)
-
Navigating the heterogeneous landscape of pediatric Kaposi sarcoma
- William Kamiyango
- Jimmy Villiera
- Nader Kim El-Mallawany
Cancer and Metastasis Reviews (2019)